Skip to content
10-K

Annual Report

Immune Design Corp.

0001437786-18-000013

← back to feed
Filed
Mar 14, 2018 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2017 · Mar 12, 2018 48.13M sh
Revenue FY 2017 · Dec 31, 2017 $7.2M
Revenue FY 2017 · Dec 31, 2016 $2.06M
Revenue FY 2017 · Dec 31, 2016 $13.26M
Revenue FY 2017 · Sep 30, 2016 $8.21M
Revenue FY 2017 · Jun 30, 2016 $1.13M
Revenue FY 2017 · Mar 31, 2016 $1.86M
Revenue FY 2017 · Dec 31, 2015 $9.51M
Current Liabilities FY 2017 · Dec 31, 2016 $19.26M
Current Assets FY 2017 · Dec 31, 2016 $114.08M
Total Assets FY 2017 · Dec 31, 2016 $114.5M
Capex FY 2017 · Dec 31, 2015 $427K
Cash And Equivalents FY 2017 · Dec 31, 2015 $112.92M
Cash And Equivalents FY 2017 · Dec 31, 2014 $75.35M
Sga Expense FY 2017 · Dec 31, 2015 $15.13M
Rd Expense FY 2017 · Dec 31, 2015 $33.09M
Net Income FY 2017 · Dec 31, 2015 −$39.45M
Operating Income FY 2017 · Dec 31, 2015 −$39.49M
Stockholders Equity FY 2017 · Dec 31, 2014 $66.35M